CellCept 250 Roche (Cellcept 250 mg)
Generic Name: mycophenolate mofetil
Pill imprint CellCept 250 Roche has been identified as Cellcept 250 mg.
CellCept is used in the treatment of nephrotic syndrome; organ transplant, rejection prophylaxis and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. CellCept 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- mycophenolate mofetil
- CellCept 250 Roche
- 250 mg
- Orange & Turquoise
- 19.00 mm
- Prescription only
- Drug Class:
- Selective immunosuppressants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Roche Laboratories
- National Drug Code (NDC):
- Inactive Ingredients:
- croscarmellose sodium
FD&C Blue No. 2
ferric oxide yellow
ferric oxide red
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|68258-9073||Dispensing Solutions Inc. (repackager)|
|21695-0171||Rebel Distributors Corp (repackager)|
|49999-0936||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.
More about CellCept (mycophenolate mofetil)
- CellCept capsules
- CellCept solution
- CellCept suspension
- Cellcept (Advanced Reading)
- Cellcept Oral (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.